AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Has Abbott Laboratories (NYSE:ABT) Lost Momentum in the Healthcare Sector?
March 28, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Five-year share price performance has trailed broader market trends.,Share price growth lags behind reported net profitability growth.,Total shareholder return outpaces price return, supported by dividends.,Abbott Laboratories,(NYSE:ABT),o...
What’s Behind Johnson & Johnson’s Latest FDA Fast Track Designations?
March 28, 2025 08:08 AM AEDT| By Team Kalkine MediaWhat’s Behind Johnson & Johnson’s Latest FDA Fast Track Designations?
Is Eli Lilly Expanding Its Reach With New Healthcare Innovations?
March 28, 2025 07:41 AM AEDT| By Team Kalkine MediaIs Eli Lilly Expanding Its Reach With New Healthcare Innovations?
How Will Cigna’s New Leadership Drive Asia Pacific Expansion?
March 28, 2025 07:23 AM AEDT| By Team Kalkine MediaHow Will Cigna’s New Leadership Drive Asia Pacific Expansion?
Is MannKind Co. Shaping the Future of Inhaled Therapeutics?
March 27, 2025 07:21 PM AEDT| By Team Kalkine MediaIs MannKind Co. Shaping the Future of Inhaled Therapeutics?
Is Protagonist Therapeutics Leading a Shift in Biopharmaceutical Innovation?
March 27, 2025 07:20 PM AEDT| By Team Kalkine MediaHighlights,• Swiss National Bank expanded its stake in Protagonist Therapeutics (PTGX).,• Recent quarterly earnings surpassed previous performance measures with strong revenue and margins.,• Key executives adjusted personal holdings as documented in...
The Swiss National Bank Increases Its Stock Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
March 27, 2025 07:13 PM AEDT| By Team Kalkine MediaHighlights,Swiss National Bank increased its stake in Recursion Pharmaceuticals (NASDAQ:RXRX) during the fourth quarter.,Multiple institutional investors expanded their holdings in the biotechnology company.,Recursion Pharmaceuticals continues advanc...
Is Medpace Holdings Facing Unforeseen Hurdles?
March 27, 2025 06:29 PM AEDT| By Team Kalkine MediaHighlights,Hightower Advisors LLC modifies its portfolio with regard to Medpace Holdings Inc.,The transaction is recorded within the healthcare investment sector.,Institutional portfolio changes draw attention as part of routine reconfigurations.,In...
How Is Institutional Interest Shaping Humacyte’s (NASDAQ:HUMA) Position in Bioengineering?
March 27, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Charles Schwab Investment Management increased its holdings in Humacyte by a notable margin during the fourth quarter.,Other firms such as Vontobel Holding and ACT Wealth Management established new positions, boosting overall institutional...
Is PTC Inc. (NASDAQ:PTC) Seeing Renewed Focus from Financial Firms?
March 27, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Multiple investment firms, including Avantax Advisory Services and Cerity Partners LLC, adjusted positions in PTC Inc.,PTC’s stock has fluctuated within a year-to-date price range between its lowest and highest points in the past twelve mo...
Is Iradimed Corporation (NASDAQ:IRMD) Gaining Ground in the Medical Device Sector?
March 27, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Multiple institutional firms, including Avantax Advisory Services Inc., increased their positions in Iradimed Corporation during the fourth quarter.,Strategic adjustments from Principal Financial Group Inc. and Jacobs Levy Equity Managemen...
Is Edgewise Therapeutics Inc Facing Severe Doubts?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Broker consensus has been reported for Edgewise Therapeutics Inc.,The news centers on institutional perceptions in the biotechnology sector.,The information emerges amid evolving market sentiments.,Edgewise Therapeutics Inc. (NASDAQ:EWTX)...
Could Vor Biopharma's Average Rating Soon Turn Sour?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Vor Biopharma Inc receives an average consensus rating from market experts.,Detailed internal records capture the evaluation process.,Communication reflects systematic administrative review procedures.,Vor Biopharma Inc (NYSE:VOR) operates...
Could Astrana Health's Rating Collapse Trigger Crisis?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Astrana Health Inc receives an average consensus rating from market experts.,Detailed internal records capture the evaluation process.,Communication reflects systematic administrative review procedures.,Astrana Health Inc (NASDAQ:ASTH) ope...
Could Astrana Health's Rating Collapse Trigger Crisis?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Astrana Health Inc receives an average consensus rating from market experts.,Detailed internal records capture the evaluation process.,Communication reflects systematic administrative review procedures.,Astrana Health Inc (NASDAQ:ASTH) ope...
Could Atara and Genocea Comparison Uncover Major Flaws?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Internal documentation compares Atara Biotherapeutics and Genocea Biosciences.,Detailed records capture a systematic comparative review.,Communication reflects objective administrative evaluations.,Atara Biotherapeutics (NASDAQ:ATRA) and G...
Could Reviva Pharmaceuticals' Outcome Hide a Deeper Flaw?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Reviva Pharmaceuticals Holdings Inc receives a standard evaluation outcome.,Internal procedures document comprehensive review practices.,The factual communication emphasizes objective process adjustments.,Operating within the biotechnology...
Could Applied DNA Sciences' Decrease Hide Unseen Challenges?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Applied DNA Sciences Inc experiences a marked decrease in short interest.,Comprehensive internal reviews document the procedural changes.,The communication offers a clear, objective account of current operational adjustments.,Active in the...
Could Annovis Bio's Consensus Rating Spell Trouble?
March 27, 2025 05:23 PM AEDT| By Team Kalkine MediaHighlights,Annovis Bio Inc receives a consensus recommendation from brokerages.,Internal records document the rating process.,Communication details systematic administrative reviews.,Annovis Bio Inc (NYSE:ANVS) operates within the biotechnology secto...
Is Stevanato Group Benefiting From Healthcare Industry Trends?
March 27, 2025 07:45 AM AEDT| By Team Kalkine MediaIs Stevanato Group Benefiting from Healthcare Industry Trends?
